CTQ Q3-FY26 Activities Report & Appendix 4C
| Stock | Careteq Ltd (CTQ.ASX) |
|---|---|
| Release Time | 30 Apr 2026, 4:26 p.m. |
| Price Sensitive | Yes |
CTQ Q3-FY26 Activities Report & Appendix 4C
- Positive operating cash flow; EHS divestment completed
- Careteq refocuses on HMR Referrals
- Capital raising announced to strengthen balance sheet
Careteq Limited (ASX: CTQ) reported customer receipts of $2.2m for the quarter and generated positive net operating cash flow of $14k, improving from a $95k operating cash outflow in the prior quarter. The company completed the sale of Embedded Health Solutions (EHS) for $5.0m less adjustments, enabling it to recalibrate its balance sheet and focus on the growth of its HMR Referrals platform. Careteq also announced a two-tranche capital raising of approximately $2.2m before costs to strengthen its balance sheet. The company is now focused on refining and executing a revised business plan for HMR Referrals, including accelerating referral growth, assessing technology and platform requirements, aligning the operating cost base, and pursuing partnership opportunities.
The company did not provide any high-importance, price-sensitive forward-looking financial metrics.
Careteq is focused on positioning HMR Referrals as a focused, scalable and progressively technology-enabled platform in the home medication review sector while maintaining disciplined overhead management and preserving balance sheet flexibility.